1.0GCRF Biopharmahttps://research.kent.ac.uk/gcrfbiopharmaGCRF Biopharmahttps://research.kent.ac.uk/gcrfbiopharmaJames Budge - GCRF Biopharma - Research at Kentrich600338<blockquote class="wp-embedded-content" data-secret="k3Eqh6xk1H"><a href="https://research.kent.ac.uk/gcrfbiopharma/person/dr-james-budge/">James Budge</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://research.kent.ac.uk/gcrfbiopharma/person/dr-james-budge/embed/#?secret=k3Eqh6xk1H" width="600" height="338" title="“James Budge” — GCRF Biopharma" data-secret="k3Eqh6xk1H" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://research.kent.ac.uk/gcrfbiopharma/wp-includes/js/wp-embed.min.js
</script>
https://research.kent.ac.uk/gcrfbiopharma/wp-content/uploads/sites/1441/2018/01/budge-crop-2.jpg16511652Dr. James Budge completed his PhD at the University of Kent in 2015 where he worked on engineering Chinese Hamster Ovary (CHO) cells to improve transient gene expression processes. Subsequently he worked as a Postdoctoral Research Associate (PDRA) on an IBCatalyst funded project which focussed on the commercialisation of a novel CHO host. He currently […]